Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. (Q54523915)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. |
scientific article |
Statements
Sorafenib in combination with capecitabine: an oral regimen for patients with HER2-negative locally advanced or metastatic breast cancer. (English)
José Baselga
José Getúlio Martins Segalla
Henri Roché
Auro Del Giglio
Hélio Pinczowski
Eva M Ciruelos
Sebastião Cabral Filho
Patricia Gómez
Brigitte Van Eyll
Begoña Bermejo
Antonio Llombart
Bernardo Garicochea
Miguel Ángel Climent Durán
Paulo Marcelo Gehm Hoff
Marc Espié
Andre Augusto Junior Gemeinder de Moraes
Ronaldo Albuquerque Ribeiro
Clarissa Mathias
Miguel Gil Gil
Belén Ojeda
Josefa Morales
Sunhee Kwon Ro
Shell Li
Frederico Costa
12 March 2012
30
13
1484-1491